SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening
Kirill Gorshkov(National Center for Advancing Translational Sciences), Wei Zheng(Liaoning Cancer Hospital & Institute), Juan Carlos de la Torre(Scripps Research Institute), Desarey Morales Vasquez(Texas Biomedical Research Institute), Luis Martínez‐Sobrido(Texas Biomedical Research Institute), Bruce Nguyen Tran(National Center for Advancing Translational Sciences), Thomas M. Moran(University of Utah), Catherine Z. Chen(National Institutes of Health), Chengjin Ye(Texas Biomedical Research Institute), Kevin Chiem(Texas Biomedical Research Institute)
Cited by 11
Related Papers
The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis
|Immunity|2016|600
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
|The Lancet Microbe|2021|435